Bynder Kicks Off Peak Shopping Season by Serving a Record 6 Billion Assets - Powering Exceptional Global Content Experiences Online
9.12.2024 16:07:00 CET | Business Wire | Press release
Bynder, a global leader in AI-powered enterprise DAM, has helped a number of global brands break Black Friday and Cyber Monday records by delivering exceptional content experiences at scale across a number of worldwide e-commerce channels.
During the seven day period (November 27 - Dec 2 2024) which included Black Friday, Small Business Saturday, and Cyber Monday, Bynder’s Content Experiences (CX) for Omnichannel solution was responsible for serving more than 6 billion assets to over 70,000 websites, with more than 4.5 billion asset transformations undertaken.
The figures represent a 15% increase in assets delivered vs 2023, plus 67% more assets were delivered through CX for Omnichannel on Black Friday than an average day in 2024.
Customers such as Sur La Table, Bose, Raymour & Flanigan and Puma used CX for Omnichannel to deliver targeted and optimized content at scale to their digital channels over the busiest shopping days. Bynder customers were able to utilize the assets stored in their Bynder DAM and transform and deliver them to their digital channels, including their website, e-commerce sites, emails and social media.
Bynder’s DAM sits at the heart of a brand’s martech stack as the system of record for digital assets, while Bynder’s CX for Omnichannel solution is the delivery technology that connects the DAM to a brand’s tech ecosystem and automates delivering optimized assets for each digital channel in real time.
For consumer brands that are delivering seasonal shopping content across a number of e-commerce platforms, Bynder’s solution can transform, optimize and deliver targeted content experiences based on the channel and audience automatically, that boost return on investment all while ensuring brand consistency, improved website performance and increase in conversions for e-commerce sites.
According to a NielsenIQ study analyzed by Barcelona's OBS Business School, Black Friday has become one of the most anticipated European retail periods in the run-up to the holiday season, with 61% of consumers in Spain, the UK, Italy, France, and Germany expected to have participated in Black Friday. While in the US, a record 200.4 million consumers shopped over the five-day holiday weekend from Thanksgiving Day through Cyber Monday, surpassing last year’s record of 196.7 million.
When creating and managing seasonal assets, a survey by Bynder revealed that 51% of marketers agreed that more marketing assets are required for Black Friday than any other seasonal holiday. The biggest challenge stated for just over one in three (36%) respondents was managing the number of assets they were creating for the peak shopping season.
Sur La Table, a retailer known for a variety of upscale cooking and dining supplies, is one such brand scaling its content delivery through Bynder during the holiday peak period.
Blake Bakanoff, VP of Creative at Sur La Table, said, “A good tool improves the way we work. A great partner improves the way we think, make and move.At Sur La Table, bringing value to our customers, by creating exceptional culinary content, lies at the core of our brand. We’re “Makers” at heart, and Bynder’s CX for Omnichannel solution empowers us to create, adapt, and deliver a wealth of custom content tailored to every channel—whether it’s showcasing thoughtful gift ideas on Instagram, sharing original holiday recipes through email, or engaging customers as they explore our website. By connecting our teams and external partners to our extensive content catalog delivering 165M+ assets, Bynder enables us to inspire and delight our customers with curated, memorable experiences during the peak holiday season."
Peter-Paul Houtman, CTO at Bynder, said: “The period between Thanksgiving and Cyber Monday represents some of the busiest days for e-commerce retailers. The volume of shoppers has increased over time and so has the volume of products that are available at a discount. E-commerce retailers are dealing with a higher volume of transactions and they need a scalable AI-powered enterprise grade platform like Bynder’s DAM, as well as its Content Experiences (CX) for Omnichannel solution, to deliver exceptional content experiences for their customers during these peak times.
“A unified omnichannel approach in terms of managing assets and delivering assets digitally ensures no opportunity is missed during peak retail seasons and by using Content Experiences for Omnichannel, leading brands can supercharge their marketing strategies and boost engagement by creating targeted content experiences across a number of digital touchpoints, improving website performance and conversions to bring real return-on-investment to businesses.”
For more information on Bynder’s DAM, please visit: https://www.bynder.com/en/products/digital-asset-management/ and for more information on Content Experiences (CX) for Omnichannel, please visit: https://www.bynder.com/en/products/content-experiences-for-omnichannel/
View source version on businesswire.com: https://www.businesswire.com/news/home/20241209828157/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom